Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016911
Filing Date
2022-08-11
Accepted
2022-08-11 16:29:17
Documents
80
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20220630.htm   iXBRL 10-Q 3236382
2 EX-10.1 aura-ex10_1.htm EX-10.1 1580108
3 EX-31.1 aura-ex31_1.htm EX-31.1 23618
4 EX-31.2 aura-ex31_2.htm EX-31.2 23574
5 EX-32.1 aura-ex32_1.htm EX-32.1 22249
6 GRAPHIC img110370785_0.jpg GRAPHIC 191679
7 GRAPHIC img110370785_1.jpg GRAPHIC 497601
  Complete submission text file 0000950170-22-016911.txt   12905340

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aura-20220630_def.xml EX-101.DEF 257173
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aura-20220630.xsd EX-101.SCH 64228
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aura-20220630_cal.xml EX-101.CAL 45311
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aura-20220630_pre.xml EX-101.PRE 368980
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aura-20220630_lab.xml EX-101.LAB 491940
74 EXTRACTED XBRL INSTANCE DOCUMENT aura-20220630_htm.xml XML 1745706
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 221156303
SIC: 2836 Biological Products, (No Diagnostic Substances)